Modified Activities Scale for Kids‐performance (ASKp) score (0 to 100%: best outcome) at 4 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Treatment failure (4 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
It is very uncertain whether summary of findings. Removable splintage changes treatment failure (4 weeks compared with cast (very low certainty).
1 finding from 1 review
Serious adverse events (6 months · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Return to normal activities (days) · children with stable wrist fracture, predominantly buckle (torus) fracturesa
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Minor complications (3 to 6 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Participant satisfaction: child and/or parent preference for same device in future (3 to 6 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Mean GI symptom scores · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Proteolytic enzymes may leads to lower acute and late GI toxicity (grade 2+) compared with control (placebo or no intervention) (low certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
It is very uncertain whether summary of findings: Proteolytic enzymes changes diarrhoea (grade 2+) compared with control (placebo or no intervention) (very low certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Reduced dose volume showed no clear difference in acute and late GI toxicity (grade 2+) compared with standard dose volume (moderate certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores (lower is better) · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
It is very uncertain whether summary of findings: Protein supplements changes diarrhoea (grade 2+) compared with no intervention (very low certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Fresh frozen plasma changes incidence of hepatic veno‐occlusive disease ( compared with no treatment (very low certainty).
1 finding from 1 review